Table 4 Predictors of adverse events and post-pPCI heart failure
Predictor | OR (95% CI) | p-value |
|---|---|---|
Predictors of adverse events in the whole study group | ||
Age group (> 45 years) | 2.757 (1.378–5.519) | 0.004 |
Male sex | 0.895 (0.539–1.487) | 0.670 |
Diabetes mellitus | 1.801 (1.164–2.785) | 0.008 |
Serum creatinine | 2.132 (1.191–3.817) | 0.011 |
EF | 0.934 (0.901–0.970) | < 0.001 |
LVEDD | 1.061 (1.008–1.117) | 0.025 |
WMS Index | 12.686 (4.843–23.226) | 0.005 |
Predictors of adverse events in young STEMI patients (< 45 years) | ||
Male sex | 1.048 (0.416–2.159) | 0.898 |
Hypertension | 2.794 (1.165–6.698) | 0.021 |
Dyslipidemia | 3.138 (1.102–8.941) | 0.032 |
FH of p-CAD | 0.029 (0.004–0.205) | < 0.001 |
e-GFR | 0.955 (0.936–0.975) | < 0.001 |
Predictors of post-pPCI heart failure in the whole group | ||
Age group (> 45 years) | 2.096 (1.195–3.674) | 0.010 |
Male sex | 0.705 (0.393–1.264) | 0.241 |
Hypertension | 1.677 (1.131–2.486) | 0.010 |
e-GFR | 0.987 (0.975–0.998) | 0.025 |
WMS index | 8.766 (1.192–14.408) | 0.012 |